Angelini Ventures
Headquarter
Global Headquarter: Jacksonville, FL, US
Innovation & Operations Center of Excellence in Pisa, Italy
Milestones
Founded: 2015
Invested: 2026
CEO
Mark Toland, Founder and CEO
Vertical
Medtech
Board Participation
Tanja Dowe, Board Member
MMI (Medical Microinstruments) is the company behind Symani, the only commercially available robotic system built specifically for microsurgery and supermicrosurgery — procedures on structures as small as 0.3mm, beyond the reach of the unaided human hand. Combining motion scaling, tremor elimination, and the world's smallest wristed instruments, Symani is already helping surgeons at leading medical centers perform more precise reconstructive and lymphatic procedures, with new research underway into neurodegenerative applications such as Alzheimer's. Angelini Ventures backed MMI's Series D round in 2026.
Related news:
EIB-Angelini Ventures Partnership Reaches €68.5 Million with New Investment in MMI